Abstract
Rationale
Characterizing the neuroanatomical basis of serotonergic abnormalities in severe, chronic, impulsive aggression will allow for rational treatment selection, development of novel therapeutics, and biomarkers to identify at-risk individuals.
Objectives
The aim of this study is to identify associations between regional serotonin transporter (5-HTT) availability and trait and state aggression, as well as response to the anti-aggressive effects of fluoxetine.
Methods
We examined 5-HTT availability using positron emission tomography (PET) imaging with [11C]DASB in personality disordered patients with current physical intermittent explosive disorder (IED; n = 18), and healthy comparison participants (HC; n = 11), in the anterior cingulate cortex (ACC), amygdala (AMY), ventral striatum (VST), and midbrain (MID). After PET imaging, IED patients were treated with fluoxetine 20 mg daily (n = 9) or placebo (n = 6) for 12 weeks. Trait and state aggression, trait callousness, and childhood trauma were assessed.
Results
In IED patients, trait aggression was positively associated with [11C]DASB binding in the ACC and VST; covarying for trait callousness and childhood trauma enhanced these correlations. Baseline state aggression was positively correlated with ACC [11C]DASB in IED patients. Greater baseline VST [11C]DASB binding predicted greater decreases in state aggression with fluoxetine treatment.
Conclusions
Consistent with prior reports, ACC 5-HTT is related to trait aggression, and adjusting for factors related to proactive (callousness) and reactive (childhood trauma) aggression subtypes further resolves this relationship. Novel findings of the study include a better understanding of the association between regional 5-HTT availability and state aggression, and the involvement of VST 5-HTT with trait aggression, and with the anti-aggressive effects of fluoxetine.
Similar content being viewed by others
Abbreviations
- 5-HT:
-
5-Hydroxytryptamine or serotonin
- 5-HTT:
-
Serotonin transporter
- ACC:
-
Anterior cingulate cortex
- AMY:
-
Amygdala
- ASPD:
-
Antisocial personality disorder
- AvPD:
-
Avoidant personality disorder
- BPAQ:
-
Buss-Perry aggression questionnaire
- BPD:
-
Borderline personality disorder
- CTQ:
-
Childhood trauma questionnaire
- CU:
-
Callous-unemotional
- DAPP:
-
Dimensional assessment of pathological personality
- HC:
-
Healthy comparison
- IED:
-
Intermittent explosive disorder
- MAO-A:
-
Monoamine oxidase-A
- MRI:
-
Magnetic resonance imaging
- MID:
-
Midbrain
- NPD:
-
Narcissistic personality disorder
- OAS-M:
-
Overt aggression scale-modified
- OCPD:
-
Obsessive-compulsive personality disorder
- PDNOS:
-
Personality disorder not otherwise specified
- PET:
-
Positron emission tomography
- PPD:
-
Paranoid personality disorder
- ROI:
-
Region of interest
- SPD:
-
Schizotypal personality disorder
- SSRI:
-
Serotonin specific reuptake inhibitor
- Verb/Phys:
-
Verbal and physical
- VST:
-
Ventral striatum
References
Abi-Dargham A, Martinez D, Mawlawi O, Simpson N, Hwang DR, Slifstein M, Anjilvel S, Pidcock J, Guo NN, Lombardo I, Mann JJ, Van Heertum R, Foged C, Halldin C, Laruelle M (2000) Measurement of striatal and extrastriatal dopamine D-1 receptor binding potential with [C-11]NNC 112 in humans: validation and reproducibility. J Cerebr Blood F Met 20:225–243
Aggarwal S, Mortensen OV (2017) Overview of monoamine transporters. Curr Protoc Pharmacol 79:12 16 1-12 16 17
Aluja A, Garcia LF, Blanch A, De Lorenzo D, Fibla J (2009) Impulsive-disinhibited personality and serotonin transporter gene polymorphisms: association study in an inmate’s sample. J Psychiatr Res 43:906–914
Audero E, Mlinar B, Baccini G, Skachokova ZK, Corradetti R, Gross C (2013) Suppression of serotonin neuron firing increases aggression in mice. J Neurosci 33:8678–8688
Bernstein DP, Fink L, Handelsman L, Foote J, Lovejoy M, Wenzel K, Sapareto E, Ruggiero J (1994) Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry 151:1132–1136
Brugman S, Cornet LJ, Smeijers D, Smeets K, Oostermeijer S, Buitelaar JK, Verkes RJ, Lobbestael J, de Kogel CH, Jansen LM (2017) Examining the reactive proactive questionnaire in adults in forensic and non-forensic settings: A variable- and person-based approach. Aggress Behav 43:155–162
Buss AH, Perry M (1992) The aggression questionnaire. J Pers Soc Psychol 63:452–459
Cerda M, Tracy M, Keyes KM (2018) Reducing urban violence: a contrast of public health and criminal justice approaches. Epidemiology 29:142–150
Cherepkova EV, Maksimov VV, Aftanas LI (2018) Polymorphism of serotonin transporter gene in male subjects with antisocial behavior and MMA fighters. Transl Psychiatry 8:248
Chester DS, DeWall CN (2016) The pleasure of revenge: retaliatory aggression arises from a neural imbalance toward reward. Soc Cogn Affect Neurosci 11:1173–1182
Chester DS, Lynam DR, Milich R, DeWall CN (2018) Neural mechanisms of the rejection-aggression link. Soc Cogn Affect Neurosci 13:501–512
Cima M, Raine A, Meesters C, Popma A (2013) Validation of the Dutch Reactive Proactive Questionnaire (RPQ): differential correlates of reactive and proactive aggression from childhood to adulthood. Aggress Behav 39:99–113
Coccaro EF (2020) The Overt Aggression Scale Modified (OAS-M) for clinical trials targeting impulsive aggression and intermittent explosive disorder: validity, reliability, and correlates. J Psychiatr Res 124:50–57
Coccaro EF, Kavoussi RJ (1997) Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 54:1081–1088
Coccaro EF, Lee RJ, Kavoussi RJ (2009) A double-blind, randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. J Clin Psychiatry 70:653–662
Coccaro EF, Fanning JR, Phan KL, Lee R (2015) Serotonin and impulsive aggression. CNS Spectr 20:295–302
Crockett MJ, Apergis-Schoute A, Herrmann B, Lieberman MD, Muller U, Robbins TW, Clark L (2013) Serotonin modulates striatal responses to fairness and retaliation in humans. J Neurosci 33:3505–3513
da Cunha-Bang S, Hjordt LV, Perfalk E, Beliveau V, Bock C, Lehel S, Thomsen C, Sestoft D, Svarer C, Knudsen GM (2017) Serotonin 1B receptor binding is associated with trait anger and level of psychopathy in violent offenders. Biol Psychiatry 82:267–274
Daniel R, Pollmann S (2014) A universal role of the ventral striatum in reward-based learning: evidence from human studies. Neurobiol Learn Mem 114:90–100
Davidge KM, Atkinson L, Douglas L, Lee V, Shapiro S, Kennedy JL, Beitchman JH (2004) Association of the serotonin transporter and 5HT1Dbeta receptor genes with extreme, persistent and pervasive aggressive behaviour in children. Psychiatr Genet 14:143–146
Dolan MC, Anderson IM (2003) The relationship between serotonergic function and the Psychopathy Checklist: Screening Version. J Psychopharmacol 17:216–222
Fanning JR, Coleman M, Lee R, Coccaro EF (2019) Subtypes of aggression in intermittent explosive disorder. J Psychiatr Res 109:164–172
Fanning JR, Marcus DK, Preszler JR, Coccaro EF (2021) Evidence for the taxonic latent structure for DSM-5 intermittent explosive disorder in adults. Psychol Med 51:54–61
First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. (SCID-I/P) Biometrics Research. New York State Psychiatric Institute, New York
Fiskerstrand CE, Lovejoy EA, Quinn JP (1999) An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett 458:171–174
Frankle WG, Lombardo I, New AS, Goodman M, Talbot PS, Huang Y, Hwang DR, Slifstein M, Curry S, Abi-Dargham A, Laruelle M, Siever LJ (2005) Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry 162:915–923
Friston KJ, Holmes AP, Worsley KJ, Poline J-P, Frith CD, Frakowiak RSJ (1995) Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapping 2:189–210
Garcia LF, Aluja A, Fibla J, Cuevas L, Garcia O (2010) Incremental effect for antisocial personality disorder genetic risk combining 5-HTTLPR and 5-HTTVNTR polymorphisms. Psychiatry Res 177:161–166
Godar SC, Fite PJ, McFarlin KM, Bortolato M (2016) The role of monoamine oxidase A in aggression: current translational developments and future challenges. Prog Neuropsychopharmacol Biol Psychiatry 69:90–100
Haber SN, McFarland NR (1999) The concept of the ventral striatum in nonhuman primates. Ann N Y Acad Sci 877:33–48
Hallikainen T, Saito T, Lachman HM, Volavka J, Pohjalainen T, Ryynanen OP, Kauhanen J, Syvalahti E, Hietala J, Tiihonen J (1999) Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior. Mol Psychiatry 4:385–388
Hemmings SMJ, Xulu K, Sommer J, Hinsberger M, Malan-Muller S, Tromp G, Elbert T, Weierstall R, Seedat S (2018) Appetitive and reactive aggression are differentially associated with the STin2 genetic variant in the serotonin transporter gene. Sci Rep 8:6714
Holmes A, Murphy DL, Crawley JN (2002) Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology 161:160–167
Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533–1539
James GM, Baldinger-Melich P, Philippe C, Kranz GS, Vanicek T, Hahn A, Gryglewski G, Hienert M, Spies M, Traub-Weidinger T, Mitterhauser M, Wadsak W, Hacker M, Kasper S, Lanzenberger R (2017) Effects of selective serotonin reuptake inhibitors on interregional relation of serotonin transporter availability in major depression. Front Hum Neurosci 11:48
Kiryanova V, Dyck RH (2014) Increased aggression, improved spatial memory, and reduced anxiety-like behaviour in adult male mice exposed to fluoxetine early in life. Dev Neurosci 36:396–408
Kolla NJ, Malcolm C, Attard S, Arenovich T, Blackwood N, Hodgins S (2013) Childhood maltreatment and aggressive behaviour in violent offenders with psychopathy. Can J Psychiatry 58:487–494
Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153–158
Lee R, Kavoussi RJ, Coccaro EF (2008) Placebo-controlled, randomized trial of fluoxetine in the treatment of aggression in male intimate partner abusers. Int Clin Psychopharmacol 23:337–341
Lobbestael J, Cima M, Arntz A (2013) The relationship between adult reactive and proactive aggression, hostile interpretation bias, and antisocial personality disorder. J Pers Disord 27:53–66
Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834–840
Lozier LM, Cardinale EM, VanMeter JW, Marsh AA (2014) Mediation of the relationship between callous-unemotional traits and proactive aggression by amygdala response to fear among children with conduct problems. JAMA Psychiat 71:627–636
MacKenzie A, Quinn J (1999) A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci U S A 96:15251–15255
Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, Huang YY, Simpson N, Ngo K, Van Heertum R, Laruelle M (2001) Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D-2 receptor parameter measurements in ventral striatum. J Cerebr Blood F Met 21:1034–1057
Montoya ER, Terburg D, Bos PA, van Honk J (2012) Testosterone, cortisol, and serotonin as key regulators of social aggression: a review and theoretical perspective. Motiv Emot 36:65–73
Navailles S, De Deurwaerdere P (2011) Presynaptic control of serotonin on striatal dopamine function. Psychopharmacology 213:213–242
New AS, Hazlett EA, Newmark RE, Zhang J, Triebwasser J, Meyerson D, Lazarus S, Trisdorfer R, Goldstein KE, Goodman M, Koenigsberg HW, Flory JD, Siever LJ, Buchsbaum MS (2009) Laboratory induced aggression: a positron emission tomography study of aggressive individuals with borderline personality disorder. Biol Psychiatry 66:1107–1114
Olivier B, van Oorschot R (2005) 5-HT1B receptors and aggression: a review. Eur J Pharmacol 526:207–217
Perez-Rodriguez MM, Weinstein S, New AS, Bevilacqua L, Yuan Q, Zhou Z, Hodgkinson C, Goodman M, Koenigsberg HW, Goldman D, Siever LJ (2010) Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls. J Psychiatr Res 44:1075–1081
Perez-Rodriguez MM, Hazlett EA, Rich EL, Ripoll LH, Weiner DM, Spence N, Goodman M, Koenigsberg HW, Siever LJ, New AS (2012) Striatal activity in borderline personality disorder with comorbid intermittent explosive disorder: sex differences. J Psychiatr Res 46:797–804
Pfohl BB, N; Zimmerman, M. (1997) Structured Interview for DSM-IV Personality (SIDP-IV). American Psychiatric Association
Pukrop R, Steinbring I, Gentil I, Schulte C, Larstone R, Livesley JW (2009) Clinical validity of the “Dimensional Assessment of Personality Pathology (DAPP)” for psychiatric patients with and without a personality disorder diagnosis. J Pers Disord 23:572–586
Raine A, Dodge K, Loeber R, Gatzke-Kopp L, Lynam D, Reynolds C, Stouthamer-Loeber M, Liu J (2006) The reactive-proactive aggression questionnaire: differential correlates of reactive and proactive aggression in adolescent boys. Aggress Behav 32:159–171
Rosell DR, Siever LJ (2015) The neurobiology of aggression and violence. CNS Spectr 20:254–279
Rosell DR, Thompson JL, Slifstein M, Xu X, Frankle WG, New AS, Goodman M, Weinstein SR, Laruelle M, Abi-Dargham A, Siever LJ (2010) Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol Psychiatry 67:1154–1162
Runions KC, Salmivalli C, Shaw T, Burns S, Cross D (2018) Beyond the reactive-proactive dichotomy: rage, revenge, reward, and recreational aggression predict early high school bully and bully/victim status. Aggress Behav 44:501–511
Rylands AJ, Hinz R, Jones M, Holmes SE, Feldmann M, Brown G, McMahon AW, Talbot PS (2012) Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using (11)C-DASB and (11)C-MDL100907. Biol Psychiatry 72:1004–1011
Rynar L, Coccaro EF (2018) Psychosocial impairment in DSM-5 intermittent explosive disorder. Psychiatry Res 264:91–95
Sekine Y, Ouchi Y, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M, Okada H, Minabe Y, Suzuki K, Iwata Y, Tsuchiya KJ, Tsukada H, Iyo M, Mori N (2006) Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 63:90–100
Silva H, Iturra P, Solari A, Villarroel J, Jerez S, Vielma W, Montes C, Pumarino L, Roa N (2007) Serotonin transporter polymorphism and fluoxetine effect on impulsiveness and aggression in borderline personality disorder. Actas Esp Psiquiatr 35:387–392
Smeets KC, Oostermeijer S, Lappenschaar M, Cohn M, van der Meer JM, Popma A, Jansen LM, Rommelse NN, Scheepers FE, Buitelaar JK (2017) Are proactive and reactive aggression meaningful distinctions in adolescents? A variable- and person-based approach. J Abnorm Child Psychol 45:1–14
Tanaka SC, Schweighofer N, Asahi S, Shishida K, Okamoto Y, Yamawaki S, Doya K (2007) Serotonin differentially regulates short- and long-term prediction of rewards in the ventral and dorsal striatum. PLoS ONE 2:e1333
van de Giessen E, Rosell DR, Thompson JL, Xu X, Girgis RR, Ehrlich Y, Slifstein M, Abi-Dargham A, Siever LJ (2014) Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C]DASB. J Psychiatr Res 58:147–154
Acknowledgements
The authors declare no financial conflict of interest. This research was supported by Grant RO1MH063875 from the National Institute of Mental Health to Larry J. Siever and subsequently to Harold W. Koenigsberg. This publication was made possible by Grant Number MO1-RR-00071 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH).
The authors would like to thank Lauren Brickman, Cameryn Cooley, Samuel Fels, Hayley Galitzer, Nabila Hoque, Maria Martin Lopez, Jacqueline Trumbull, and Lauren Zaluda for their technical assistance on this project.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Research reported in this publication was supported by the National Institute of Mental Health of the National Institutes of Health under Award Number R01 MH063875. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare no financial conflict of interest. Dr Rosell receives a royalty from UpToDate. Dr Slifstein has consulted for Curasen Therapeutics and Neurocrine Inc., and has stock options in Storm Bioscience. Dr. Thompson has received research support from diaMentis for a project unrelated to this work. Dr. Perez-Rodriguez has received research grant funding from Neurocrine Biosciences (Inc.), Millennium Pharmaceuticals, Takeda, Merck, and AI Cure for projects unrelated to this work. She is an Advisory Board member for Neurocrine Biosciences, Inc., and a consultant on an American Foundation for Suicide Prevention (AFSP) grant (LSRG-1–005-16, PI: Baca-Garcia). She is part of the research networks “CIBERSAM” (https://www.cibersam.es/en), “WORECA” (World Research Consortium forSuicide), MEMind Working Group, and the Borderline Personality Disorder International Genetics Consortium. Dr. Hazlett is supported by a VA CSR&D Research Career Scientist Award (1 IK6 CX001738). Dr. Abi-Dargham received consulting fees and/or honoraria from Sunovion, Otsuka, Merck, Neurocrine and Intracellular Therapies. She holds stock options in Systems 1 Bio and in Terran Biosciences. Dr. Koenigsberg has received research grant funding from NIMH grants R01 MH 109730, R61 MH125130 and R01 MH123069. He receives salary support from James J Peters Veterans Affairs Medical Center.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Rosell, D.R., Slifstein, M., Thompson, J. et al. Serotonin transporter availability in physically aggressive personality disordered patients: associations with trait and state aggression, and response to fluoxetine. Psychopharmacology 240, 361–371 (2023). https://doi.org/10.1007/s00213-022-06306-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-022-06306-2